Q3 Results Preview: Pharma sector earnings growth to be driven by US generics, formulations market, says Motilal Oswal Q3 Results Preview: Pharma companies are expected to report strong YoY earnings growth of 19.7% in Q3FY24, driven by robust demand for US generics and strong results in the domestic formulation market.
Q3 Results Preview: Pharma sector earnings growth to be driven by US generics, formulations market, says Motilal Oswal
- Konuyu başlatan Bilgin
- Başlangıç tarihi